The effect of phototherapy on serum homocystein level

Not Applicable

Recruiting

• Conditions: L20-L80-L4; Atopic dermatitis-vitiligo-psoriasis.; Atopic dermatitis-vitiligo-psoriasis

• Registration Number: IRCT2017060134286N1
• Lead Sponsor: Vice chancellor for research,Babol University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

psoriasis or Vitiligo, which is set to be at least 30 sessions of light therapy NBUVB. signing the informed consent before entering the examination
Exclusion criteria: Smoking, illnesses such as hypertension, diabetes, thyroid dysfunction that may affect homocysteine levels. Use of drugs; such as vitamins, OCP and anti-coagulant. past history of cardiovascular, chronic hepatitis, chronic kidney disease, cancer and pregnancy, inflammatory bowel disease, rheumatic diseases. systemic drugs anti-psoriasis or Vitiligo. Use of natural or synthetic UV for during the months prior to admission natural or synthetic. Patients who did not complete therapy by the end of 30 sessions

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Serum homocystein levels. Timepoint: Baseline (before initiation of treatment)-after 30sessions of treatment. Method of measurement: Elisa.

Secondary Outcome Measures

Name	Time	Method
Cumulative dose. Timepoint: After 30 session phototherapy. Method of measurement: j/cm.